(WGBS) (WGBS) Stock Price, News & Analysis

Company Overview

WaferGen Bio-systems, Inc. (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company's ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company's SmartChip platform, which is also used for profiling and validating molecular biomarkers. The Company's SmartChip is a micro-fabricated chip comprising a range of massively-parallel micro wells that are physically separated from each other. It offers SmartChip System Capabilities, SmartChip Single-Cell Isolation System, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation.

Key Stats

• Today's Range: $6.90 to $6.90
• 50-Day Range: N/A
• 52-Week Range: $2.50 to $7.10
• Volume: N/A
• Average Volume: 77,872 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

WGBS Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (WGBS) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (WGBS) investors own include Aeterna Zentaris (AEZS), DarioHealth (DRIO), XOMA Royalty (XOMA), BioLineRx (BLRX), Vascular Biogenics (VBLT), Ampliphi Biosciences (APHB) and Can-Fite BioPharma (CANF).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:WGBS
• CIK: 1368993
• Web: www.wafergen.com
• Phone: +1-510-6514450
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A